Inventor Patent Infringement Patent Law Technology 
IPilogue
NOVEMBER 3, 2022
Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. Moderna claimed that they had registered foundational mRNA patents between 2010 and 2016. This exposes some concerns about our patent laws.
Patently-O
JANUARY 3, 2024
by Dennis Crouch The following is my patent law exam from this past semester. When EL filed his patent application, he named himself as the sole inventor. However, he is now questioning whether Jane or Lisa should also be listed as inventors. Question 3. What do you think?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delaware Intellectual Property Litigation Blog
SEPTEMBER 11, 2021
In Thaler , the Court confronted, analyzed and answered the question of “can an artificial intelligence machine be an ‘inventor’ under the Patent Act?” After analyzing the plain statutory language of the Patent Act and the Federal Circuit authority, the Court held that the “clear answer is no.” at *17-18.
Patently-O
MARCH 18, 2024
The patent at issue, originally naming a single inventor (Steve Campbell), claims a lightweight intermodal container system for transporting refrigerated gaseous fluids. 256 to correct inventorship on an issued patent. 256 to correct inventorship on an issued patent. Tube-Mac Indus., Campbell , No. 2022-2170 (Fed.
Patently-O
JULY 21, 2022
Symbiont’s US Patent No. The inventor Mark Holt is also owner of Symbiont. Holt was part of forming two additional companies, BJM and Matrix and Symbiont licensed the technology (including the patent) to those companies. patent laws are subject to exclusive jurisdiction of the Federal Court system.
The IP Law Blog
OCTOBER 7, 2021
If the patent has already been issued, it can be invalidated for failure to satisfy the written description requirement. billion for patent infringement was reversed for just this reason. Kite developed an immunotherapy technology using CAR to target lymphoma and leukemia cells. Recently, in Juno Therapeutics, Inc.
LexBlog IP
MARCH 21, 2022
” The paper was authored by the IPO’s Software Related Inventions Committee and the Artificial Intelligence (AI) & Other Emerging Technologies Committee, of which I am a member. These include: How to get the most out of a disclosure interview with AI inventors. Patent Office (USPTO). International Considerations.
Expert insights. Personalized for you.
116 
Let's personalize your content